advantage

2021-05-26 11:51:08 浙江昂大久力生物制药有限公司 Viewd 259
advantage

E2HSA is a combination of Exendin-4 and Human serum albumin through recombination to form a new macromolecular substance, which reduces the glomerular filtration rate and prolongs the half-life of the drug. The structure where the amino acid peptide bonds are connected makes it more stable.